Report Detail

Pharma & Healthcare Global Veterinary Anesthesia Drug Market Insights, Forecast to 2028

  • RnM4424983
  • |
  • 22 April, 2022
  • |
  • Global
  • |
  • 90 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Summary:

Market Analysis and Insights: Global Veterinary Anesthesia Drug Market
Due to the COVID-19 pandemic, the global Veterinary Anesthesia Drug market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Ketamine accounting for % of the Veterinary Anesthesia Drug global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Pet segment is altered to an % CAGR throughout this forecast period.
China Veterinary Anesthesia Drug market size is valued at US$ million in 2021, while the US and Europe Veterinary Anesthesia Drug are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Veterinary Anesthesia Drug landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Veterinary Anesthesia Drug include Dechra, LGC Group, AuroMedics, Evonik, Gedeon Richter, Midas Pharma, Fresenius Kabi AG and AstraZeneca, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Market Segments
The authors of this research report have explored the key segments: Type and Application. The report offers an in-depth breakdown of type and application segments and their sub-segments. The lucrativeness and growth potential have been looked into by the industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments based on sales, price, and revenue for the period 2017-2028. The specialists, to broaden the understanding of the users, have done value chain and raw material analysis in this section.
Segment by Type
Ketamine
Propofol
Thiopental
Others
Segment by Application
Pet
Agricultural Livestock
Others
Consequence of Covid-19 Pandemic
The authors of this study have enlightened the readers on the rise and effect of the Covid-19 outbreak on the development. They have investigated the changes brought about in the demand/supply side, consumption, supply chain, and sales/manufacturing. The readers will get familiar with the measures that have helped the key players to bring the Veterinary Anesthesia Drug market back to the pre-covid levels.
Trends & Prospects
In this segment of the report, the specialists have delved into the key growth opportunities that are likely to emerge. This will aid the key players to simplify complex issues related to business and frame future strategies to compete in this competitive environment. This section will certainly assist the players to boldly position their business.
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Outlook
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and share analysis of the prominent players are also provided in this section. They have also provided reliable sales and revenue data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Dechra
LGC Group
AuroMedics
Evonik
Gedeon Richter
Midas Pharma
Fresenius Kabi AG
AstraZeneca
Frequently Asked Questions
Which is the most lucrative product segment in the Veterinary Anesthesia Drug market?
Which are the prominent strategies of the Veterinary Anesthesia Drug market players?
Which factors are increasing the competition in the Veterinary Anesthesia Drug market?
Which are the recommendations provided by the Veterinary Anesthesia Drug industry experts?
Which region will witness rewarding growth during the forecast period?
What factors will curb the Veterinary Anesthesia Drug market growth?
Which product segment will register the fastest growth rate in the Veterinary Anesthesia Drug market?
Which emerging trends will impact the Veterinary Anesthesia Drug market growth?
Which are the high-impact rendering factors in the Veterinary Anesthesia Drug market?
Which companies will maintain their lead on the Veterinary Anesthesia Drug market?


Table of Contents

    1 Study Coverage

    • 1.1 Veterinary Anesthesia Drug Product Introduction
    • 1.2 Market by Type
      • 1.2.1 Global Veterinary Anesthesia Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
      • 1.2.2 Ketamine
      • 1.2.3 Propofol
      • 1.2.4 Thiopental
      • 1.2.5 Others
    • 1.3 Market by Application
      • 1.3.1 Global Veterinary Anesthesia Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
      • 1.3.2 Pet
      • 1.3.3 Agricultural Livestock
      • 1.3.4 Others
    • 1.4 Study Objectives
    • 1.5 Years Considered

    2 Executive Summary

    • 2.1 Global Veterinary Anesthesia Drug Sales Estimates and Forecasts 2017-2028
    • 2.2 Global Veterinary Anesthesia Drug Revenue Estimates and Forecasts 2017-2028
    • 2.3 Global Veterinary Anesthesia Drug Revenue by Region: 2017 VS 2021 VS 2028
    • 2.4 Global Veterinary Anesthesia Drug Sales by Region
      • 2.4.1 Global Veterinary Anesthesia Drug Sales by Region (2017-2022)
      • 2.4.2 Global Sales Veterinary Anesthesia Drug by Region (2023-2028)
    • 2.5 Global Veterinary Anesthesia Drug Revenue by Region
      • 2.5.1 Global Veterinary Anesthesia Drug Revenue by Region (2017-2022)
      • 2.5.2 Global Veterinary Anesthesia Drug Revenue by Region (2023-2028)
    • 2.6 North America
    • 2.7 Europe
    • 2.8 Asia-Pacific
    • 2.9 Latin America
    • 2.10 Middle East & Africa

    3 Competition by Manufacturers

    • 3.1 Global Veterinary Anesthesia Drug Sales by Manufacturers
      • 3.1.1 Global Top Veterinary Anesthesia Drug Manufacturers by Sales (2017-2022)
      • 3.1.2 Global Veterinary Anesthesia Drug Sales Market Share by Manufacturers (2017-2022)
      • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Veterinary Anesthesia Drug in 2021
    • 3.2 Global Veterinary Anesthesia Drug Revenue by Manufacturers
      • 3.2.1 Global Veterinary Anesthesia Drug Revenue by Manufacturers (2017-2022)
      • 3.2.2 Global Veterinary Anesthesia Drug Revenue Market Share by Manufacturers (2017-2022)
      • 3.2.3 Global Top 10 and Top 5 Companies by Veterinary Anesthesia Drug Revenue in 2021
    • 3.3 Global Veterinary Anesthesia Drug Sales Price by Manufacturers (2017-2022)
    • 3.4 Analysis of Competitive Landscape
      • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
      • 3.4.2 Global Veterinary Anesthesia Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
      • 3.4.3 Global Veterinary Anesthesia Drug Manufacturers Geographical Distribution
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Global Veterinary Anesthesia Drug Sales by Type
      • 4.1.1 Global Veterinary Anesthesia Drug Historical Sales by Type (2017-2022)
      • 4.1.2 Global Veterinary Anesthesia Drug Forecasted Sales by Type (2023-2028)
      • 4.1.3 Global Veterinary Anesthesia Drug Sales Market Share by Type (2017-2028)
    • 4.2 Global Veterinary Anesthesia Drug Revenue by Type
      • 4.2.1 Global Veterinary Anesthesia Drug Historical Revenue by Type (2017-2022)
      • 4.2.2 Global Veterinary Anesthesia Drug Forecasted Revenue by Type (2023-2028)
      • 4.2.3 Global Veterinary Anesthesia Drug Revenue Market Share by Type (2017-2028)
    • 4.3 Global Veterinary Anesthesia Drug Price by Type
      • 4.3.1 Global Veterinary Anesthesia Drug Price by Type (2017-2022)
      • 4.3.2 Global Veterinary Anesthesia Drug Price Forecast by Type (2023-2028)

    5 Market Size by Application

    • 5.1 Global Veterinary Anesthesia Drug Sales by Application
      • 5.1.1 Global Veterinary Anesthesia Drug Historical Sales by Application (2017-2022)
      • 5.1.2 Global Veterinary Anesthesia Drug Forecasted Sales by Application (2023-2028)
      • 5.1.3 Global Veterinary Anesthesia Drug Sales Market Share by Application (2017-2028)
    • 5.2 Global Veterinary Anesthesia Drug Revenue by Application
      • 5.2.1 Global Veterinary Anesthesia Drug Historical Revenue by Application (2017-2022)
      • 5.2.2 Global Veterinary Anesthesia Drug Forecasted Revenue by Application (2023-2028)
      • 5.2.3 Global Veterinary Anesthesia Drug Revenue Market Share by Application (2017-2028)
    • 5.3 Global Veterinary Anesthesia Drug Price by Application
      • 5.3.1 Global Veterinary Anesthesia Drug Price by Application (2017-2022)
      • 5.3.2 Global Veterinary Anesthesia Drug Price Forecast by Application (2023-2028)

    6 North America

    • 6.1 North America Veterinary Anesthesia Drug Market Size by Type
      • 6.1.1 North America Veterinary Anesthesia Drug Sales by Type (2017-2028)
      • 6.1.2 North America Veterinary Anesthesia Drug Revenue by Type (2017-2028)
    • 6.2 North America Veterinary Anesthesia Drug Market Size by Application
      • 6.2.1 North America Veterinary Anesthesia Drug Sales by Application (2017-2028)
      • 6.2.2 North America Veterinary Anesthesia Drug Revenue by Application (2017-2028)
    • 6.3 North America Veterinary Anesthesia Drug Market Size by Country
      • 6.3.1 North America Veterinary Anesthesia Drug Sales by Country (2017-2028)
      • 6.3.2 North America Veterinary Anesthesia Drug Revenue by Country (2017-2028)
      • 6.3.3 United States
      • 6.3.4 Canada

    7 Europe

    • 7.1 Europe Veterinary Anesthesia Drug Market Size by Type
      • 7.1.1 Europe Veterinary Anesthesia Drug Sales by Type (2017-2028)
      • 7.1.2 Europe Veterinary Anesthesia Drug Revenue by Type (2017-2028)
    • 7.2 Europe Veterinary Anesthesia Drug Market Size by Application
      • 7.2.1 Europe Veterinary Anesthesia Drug Sales by Application (2017-2028)
      • 7.2.2 Europe Veterinary Anesthesia Drug Revenue by Application (2017-2028)
    • 7.3 Europe Veterinary Anesthesia Drug Market Size by Country
      • 7.3.1 Europe Veterinary Anesthesia Drug Sales by Country (2017-2028)
      • 7.3.2 Europe Veterinary Anesthesia Drug Revenue by Country (2017-2028)
      • 7.3.3 Germany
      • 7.3.4 France
      • 7.3.5 U.K.
      • 7.3.6 Italy
      • 7.3.7 Russia

    8 Asia Pacific

    • 8.1 Asia Pacific Veterinary Anesthesia Drug Market Size by Type
      • 8.1.1 Asia Pacific Veterinary Anesthesia Drug Sales by Type (2017-2028)
      • 8.1.2 Asia Pacific Veterinary Anesthesia Drug Revenue by Type (2017-2028)
    • 8.2 Asia Pacific Veterinary Anesthesia Drug Market Size by Application
      • 8.2.1 Asia Pacific Veterinary Anesthesia Drug Sales by Application (2017-2028)
      • 8.2.2 Asia Pacific Veterinary Anesthesia Drug Revenue by Application (2017-2028)
    • 8.3 Asia Pacific Veterinary Anesthesia Drug Market Size by Region
      • 8.3.1 Asia Pacific Veterinary Anesthesia Drug Sales by Region (2017-2028)
      • 8.3.2 Asia Pacific Veterinary Anesthesia Drug Revenue by Region (2017-2028)
      • 8.3.3 China
      • 8.3.4 Japan
      • 8.3.5 South Korea
      • 8.3.6 India
      • 8.3.7 Australia
      • 8.3.8 China Taiwan
      • 8.3.9 Indonesia
      • 8.3.10 Thailand
      • 8.3.11 Malaysia

    9 Latin America

    • 9.1 Latin America Veterinary Anesthesia Drug Market Size by Type
      • 9.1.1 Latin America Veterinary Anesthesia Drug Sales by Type (2017-2028)
      • 9.1.2 Latin America Veterinary Anesthesia Drug Revenue by Type (2017-2028)
    • 9.2 Latin America Veterinary Anesthesia Drug Market Size by Application
      • 9.2.1 Latin America Veterinary Anesthesia Drug Sales by Application (2017-2028)
      • 9.2.2 Latin America Veterinary Anesthesia Drug Revenue by Application (2017-2028)
    • 9.3 Latin America Veterinary Anesthesia Drug Market Size by Country
      • 9.3.1 Latin America Veterinary Anesthesia Drug Sales by Country (2017-2028)
      • 9.3.2 Latin America Veterinary Anesthesia Drug Revenue by Country (2017-2028)
      • 9.3.3 Mexico
      • 9.3.4 Brazil
      • 9.3.5 Argentina

    10 Middle East and Africa

    • 10.1 Middle East and Africa Veterinary Anesthesia Drug Market Size by Type
      • 10.1.1 Middle East and Africa Veterinary Anesthesia Drug Sales by Type (2017-2028)
      • 10.1.2 Middle East and Africa Veterinary Anesthesia Drug Revenue by Type (2017-2028)
    • 10.2 Middle East and Africa Veterinary Anesthesia Drug Market Size by Application
      • 10.2.1 Middle East and Africa Veterinary Anesthesia Drug Sales by Application (2017-2028)
      • 10.2.2 Middle East and Africa Veterinary Anesthesia Drug Revenue by Application (2017-2028)
    • 10.3 Middle East and Africa Veterinary Anesthesia Drug Market Size by Country
      • 10.3.1 Middle East and Africa Veterinary Anesthesia Drug Sales by Country (2017-2028)
      • 10.3.2 Middle East and Africa Veterinary Anesthesia Drug Revenue by Country (2017-2028)
      • 10.3.3 Turkey
      • 10.3.4 Saudi Arabia

    11 Company Profiles

    • 11.1 Dechra
      • 11.1.1 Dechra Corporation Information
      • 11.1.2 Dechra Overview
      • 11.1.3 Dechra Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.1.4 Dechra Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.1.5 Dechra Recent Developments
    • 11.2 LGC Group
      • 11.2.1 LGC Group Corporation Information
      • 11.2.2 LGC Group Overview
      • 11.2.3 LGC Group Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.2.4 LGC Group Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.2.5 LGC Group Recent Developments
    • 11.3 AuroMedics
      • 11.3.1 AuroMedics Corporation Information
      • 11.3.2 AuroMedics Overview
      • 11.3.3 AuroMedics Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.3.4 AuroMedics Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.3.5 AuroMedics Recent Developments
    • 11.4 Evonik
      • 11.4.1 Evonik Corporation Information
      • 11.4.2 Evonik Overview
      • 11.4.3 Evonik Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.4.4 Evonik Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.4.5 Evonik Recent Developments
    • 11.5 Gedeon Richter
      • 11.5.1 Gedeon Richter Corporation Information
      • 11.5.2 Gedeon Richter Overview
      • 11.5.3 Gedeon Richter Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.5.4 Gedeon Richter Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.5.5 Gedeon Richter Recent Developments
    • 11.6 Midas Pharma
      • 11.6.1 Midas Pharma Corporation Information
      • 11.6.2 Midas Pharma Overview
      • 11.6.3 Midas Pharma Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.6.4 Midas Pharma Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.6.5 Midas Pharma Recent Developments
    • 11.7 Fresenius Kabi AG
      • 11.7.1 Fresenius Kabi AG Corporation Information
      • 11.7.2 Fresenius Kabi AG Overview
      • 11.7.3 Fresenius Kabi AG Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.7.4 Fresenius Kabi AG Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.7.5 Fresenius Kabi AG Recent Developments
    • 11.8 AstraZeneca
      • 11.8.1 AstraZeneca Corporation Information
      • 11.8.2 AstraZeneca Overview
      • 11.8.3 AstraZeneca Veterinary Anesthesia Drug Sales, Price, Revenue and Gross Margin (2017-2022)
      • 11.8.4 AstraZeneca Veterinary Anesthesia Drug Product Model Numbers, Pictures, Descriptions and Specifications
      • 11.8.5 AstraZeneca Recent Developments

    12 Industry Chain and Sales Channels Analysis

    • 12.1 Veterinary Anesthesia Drug Industry Chain Analysis
    • 12.2 Veterinary Anesthesia Drug Key Raw Materials
      • 12.2.1 Key Raw Materials
      • 12.2.2 Raw Materials Key Suppliers
    • 12.3 Veterinary Anesthesia Drug Production Mode & Process
    • 12.4 Veterinary Anesthesia Drug Sales and Marketing
      • 12.4.1 Veterinary Anesthesia Drug Sales Channels
      • 12.4.2 Veterinary Anesthesia Drug Distributors
    • 12.5 Veterinary Anesthesia Drug Customers

    13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

    • 13.1 Veterinary Anesthesia Drug Industry Trends
    • 13.2 Veterinary Anesthesia Drug Market Drivers
    • 13.3 Veterinary Anesthesia Drug Market Challenges
    • 13.4 Veterinary Anesthesia Drug Market Restraints

    14 Key Findings in The Global Veterinary Anesthesia Drug Study

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
        • 15.1.2 Data Source
      • 15.2 Author Details

      Summary:
      Get latest Market Research Reports on Veterinary Anesthesia Drug. Industry analysis & Market Report on Veterinary Anesthesia Drug is a syndicated market report, published as Global Veterinary Anesthesia Drug Market Insights, Forecast to 2028. It is complete Research Study and Industry Analysis of Veterinary Anesthesia Drug market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,350.00
      $8,700.00
      3,493.05
      6,986.10
      4,067.25
      8,134.50
      674,815.50
      1,349,631.00
      362,572.50
      725,145.00
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report